Secretory IgA compositions, methods of making and methods of use thereof

US10696734B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10696734-B2
Application numberUS-201615249811-A
CountryUS
Kind codeB2
Filing dateAug 29, 2016
Priority dateJan 4, 2013
Publication dateJun 30, 2020
Grant dateJun 30, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein is secretory IgA isolated from the intestinal luminal fluid and intestinal mucosal of animals such as pigs and cows. Also included are methods of isolating secretory IgA. The secretory IgA is useful in food compositions such as animal and human food compositions as well as pharmaceutical compositions to increase growth rate, improve feed efficiency, reduce gastrointestinal inflammation, reduce a risk of gastrointestinal infection in the animal, or a combination thereof.

First claim

Opening claim text (preview).

The invention claimed is: 1. A composition comprising pure, pasteurized secretory IgA isolated from intestinal luminal fluid or intestinal mucosa of a pig or a cow, wherein the pure, pasteurized SIgA composition has an E. coli 055:B5 lipopolysaccharide binding activity at least 5 times greater than pig or cow serum IgA E. coli 055:B5 lipopolysaccharide binding activity. 2. The composition of claim 1 , wherein the pure secretory IgA is greater than 75% pure. 3. The composition of claim 1 , in the form of a pharmaceutical composition further comprising a pharmaceutically acceptable excipient. 4. A composition comprising secretory IgA isolated from a source that is intestinal mucosa of a pig or a cow, wherein the concentration of secretory IgA in the isolated secretory IgA is at least twice the concentration in the source material, wherein the source material is dried intestinal mucosa, an aqueous preparation from intestinal mucosa, or a dry preparation of proteins prepared from intestinal mucosa, wherein the secretory IgA is pasteurized, wherein the pure, pasteurized SIgA composition has an E. coli 055:B5 lipopolysaccharide binding activity at least 5 times greater than pig or cow serum IgA E. coli 055:B5 lipopolysaccharide binding activity. 5. The composition of claim 4 , wherein greater than 5% of the protein in the isolated secretory IgA comprises IgA. 6. The method of claim 1 , wherein pasteurization is at 50-100° C. for 30 seconds. 7. The method of claim 1 , wherein pasteurization is at 120-150° C. for 1-8 seconds. 8. The method of claim 4 , wherein pasteurization is at 50-100° C. for 30 seconds. 9. The method of claim 4 , wherein pasteurization is at 120-150° C. for 1-8 seconds.

Assignees

Inventors

Classifications

  • for poultry · CPC title

  • against material from animals or humans · CPC title

  • for aquatic animals, e.g. fish, crustaceans or molluscs · CPC title

  • characterized by taxonomic origin · CPC title

  • for horses · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10696734B2 cover?
Described herein is secretory IgA isolated from the intestinal luminal fluid and intestinal mucosal of animals such as pigs and cows. Also included are methods of isolating secretory IgA. The secretory IgA is useful in food compositions such as animal and human food compositions as well as pharmaceutical compositions to increase growth rate, improve feed efficiency, reduce gastrointestinal infl…
Who is the assignee on this patent?
Wisconsin Alumni Res Found, Wisconsin Alumni Researcg Found
What technology area does this patent fall under?
Primary CPC classification C07K16/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).